ADB-PINACA
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
JSmol) | |
| |
|
ADB-PINACA is a
CB2 receptor with EC50 values of 0.52 nM and 0.88 nM respectively.[1][2] Like MDMB-FUBINACA, this compound incorporates the unnatural amino acid tert-leucine
.
Side effects
ADB-PINACA has been linked to multiple hospitalizations and deaths due to its use.[3][4][5]
Metabolism
Nineteen ADB-PINACA major metabolites were identified in several incubations with cryopreserved human hepatocytes. Major metabolic reactions included pentyl hydroxylation, hydroxylation followed by oxidation (ketone formation), and glucuronidation.[6]
Legality
ADB-PINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[7]
In the United States, it is a
Schedule I controlled substance.[8] but its 5'-bromo analog ADB-5'Br-PINACA
is not as of October 20th, 2023.
As of October 2015 ADB-PINACA is a controlled substance in China.[9]
See also
References
- PMID 26134475.
- ^ "ADB-PINACA". Forendex. Archived from the original on 2014-07-14. Retrieved 2014-07-09.
- ^ "CDC: 221 sickened by synthetic pot in Colorado". USA Today. December 12, 2013.
- PMID 25726258.
- PMID 26154784.
- PMID 28302730.
- ^ "CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Archived from the original on 15 July 2015. Retrieved 24 July 2015.
- PMID 24605391.
- ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.